Donate

Grants and Research Funding Opportunities

Bladder Cancer Research Saves Lives

See overview of all BCAN research grants and awards

The Bladder Cancer Advocacy Network (BCAN) is committed to supporting bladder cancer research. From its inception, BCAN has cultivated a strong partnership with the leading members of the bladder cancer medical community to encourage collaboration among all the parties dedicated to the study of bladder cancer and its prevention, diagnosis and treatment. BCAN’s current research priorities are guided by the Bladder Cancer Research Network (BRCN) Management Committee.

Our goal is to identify the best and most promising research that will provide the greatest opportunity to advance the understanding of bladder cancer and improve management and treatment of this disease. BCAN raises funds and awards grants to support early investigators as well as innovative bladder cancer research to develop lifesaving treatments and improve patient outcomes.

BCAN’s Grants and Research Funding Mechanisms:

  • Research Innovation Award

    The BCAN Bladder Cancer Research Innovation Awards support exceptionally novel, high-risk, high-reward projects with great potential to produce breakthroughs in our understanding of bladder cancer.

    Learn more

  • Bladder Cancer Career Development Award

    Supporting junior investigators who have yet to secure their first major research funding but aim to establish an independent bladder cancer research program.

    Learn more

  • Young Investigator and Patient-Centered Clinical Research Awards

    BCAN’s Young Investigator Awards support outstanding early-career scientists who have a commitment to improving the understanding and treatment of bladder cancer.

    Learn more

  • John Quale Travel Fellows

    The John Quale Travel Fellowship (JQTF) Program is a special opportunity for early career investigators to attend the annual Bladder Cancer Think Tank Meeting.

    Learn more

     

  • Translational Clinical Trial Award

    The 2022 Translational Clinical Trial Award (TCTA) supports early-phase patient-oriented research to revolutionize bladder cancer care.

    Learn more

Read Our Stories